scispace - formally typeset
J

Jeffrey L. Lennox

Researcher at Emory University

Publications -  95
Citations -  7717

Jeffrey L. Lennox is an academic researcher from Emory University. The author has contributed to research in topics: Viral load & Raltegravir. The author has an hindex of 42, co-authored 94 publications receiving 7236 citations. Previous affiliations of Jeffrey L. Lennox include Grady Memorial Hospital.

Papers
More filters
Journal ArticleDOI

Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000.

TL;DR: Prolonged survival was associated with receiving therapy that including clarithromycin and receiving combination antiretroviral therapy that included a protease inhibitor and with receiving antimicrobial prophylaxis, but 32 (89%) of 36 patients did not adhere to the proPHylaxis regimen.
Journal ArticleDOI

Clinical Comparison of an Enhanced-Sensitivity Branched-DNA Assay and Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma

TL;DR: The performance characteristics of an enhanced-sensitivity branched-DNA assay (bDNA) and a reverse transcription (RT)-PCR assay (RT-PCR) were compared in a molecular diagnostic laboratory and one non-B subtype was recognized in clinical specimens based on the ratio of values obtained with the two methods.
Journal ArticleDOI

Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection

TL;DR: The data suggest that ART-induced bone loss occurs early, is aligned with early events of immune reconstitution, and these immune changes provide a unifying mechanism to explain in part the skeletal decline common to all ART.
Journal ArticleDOI

Prospective study of etiologic agents of community-acquired pneumonia in patients with Hiv infection

TL;DR: Despite the use of extensive testing, a definite etiology in a large number of cases of pneumonia was not found and the rarity of ‘atypical agents’ could simplify the empiric approach to therapy.